NXPL · NextPlat Corp

Mr. Armas is the sole member and managing partner of Apollo Two MSO LLC and has voting and dispositive power over the reported shares.

Mr. Delgado is the manager of Trident Warfare LLC and has voting and dispositive power over the reported shares.

Mr. Armas is the sole member and managing partner of Apollo Two MSO LLC and has voting and dispositive power over the reported shares.

In connection with the Merger, the Report Person received stock options to acquire 233,682 shares of the Issuer's common stock in exchange for stock options to acquire 157,203 shares of Progressive Care Inc. The options are fully vested.

In connection with the Merger, the Reporting Person received stock options to acquire 186,946 shares of the Issuer's common stock in exchange for stock options to acquire 125,762 shares of Progressive Care Inc. The stock options are fully vested.

On October 1, 2024, the Reporting Person received 127,675 shares of the Issuer's common stock in exchange for 85,890 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.

On October 1, 2024, the Reporting Person received 638,522 shares of the Issuer's common stock in exchange for 429,547 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.

Mr. Barreto is the president of RLB Market Investments, LLC and has voting and dispotive power over the reported securities.

On October 1, 2024, the Reporting Person received 27,145 shares of the Issuer's common stock in exchange for 18,261 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.

On October 1, 2024, the Reporting Person received 31 shares of the Issuer's common stock in exchange for 21 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.

On October 1, 2024, the Reporting Person received 638,522 shares of the Issuer's common stock in exchange for 429,547 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.

On October 1, 2024, the Reporting Person received 60,566 shares of the Issuer's common stock in exchange for 40,744 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.

Mr. Armas is the sole member and managing partner of Apollo Two MSO LLC and has voting and dispositive power over the reported shares.

On October 1, 2024, the Reporting Person received 60,566 shares of the Issuer's common stock in exchange for 40,744 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.

In connection with the Merger, the Reporting Person indirectly received 687,038 shares of the Issuer's common stock in exchange for 462,185 shares of Progressive Care Inc. through eAperion Partners LLC. On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.

Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC and has voting and dispotive power over the reported shares.

On April 16, 2024, Mr. Miller purchased 5,000 shares of the Company's common stock in the open market at a price of $1.43 per share.

The options were granted pursuant to the Issuer's 2021 Incentive Award Plan.

On April 7, 2023, Ms. Munnik entered into a Stock Option Agreement with the Issuer pursuant to which Ms. Munnik was granted an option to purchase 5,000 shares of Issuer's common stock, of which one third of the shares of common stock vest immediately on the Grant Date, with options to purchase an additional third of the shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining third of the shares of common stock vesting on the second-year anniversary of the Grant Date.

On April 7, 2023, Ms. Munnik entered into a Restricted Stock Award Agreement with the Issuer, pursuant to which Ms. Munnik was awarded 5,000 shares of Issuer's common stock. The restricted stock vests immediately upon issuance.

The options were granted pursuant to the Issuer's 2021 Incentive Award Plan.

On April 7, 2023, Mr. Bedwell entered into a Restricted Stock Award Agreement with the Issuer, pursuant to which Mr. Bedwell was awarded 5,000 shares of Issuer's common stock. The restricted stock vests immediately upon issuance.

The options were granted pursuant to the Issuer's 2021 Incentive Award Plan.

The options were granted pursuant to the Issuer's 2021 Incentive Award Plan.

On April 7, 2023, Mr. Bedwell entered into a Stock Option Agreement with the Issuer pursuant to which Mr. Bedwell was granted an option to purchase 5,000 shares of Issuer's common stock, of which one third of the shares of common stock vest immediately on the Grant Date, with options to purchase an additional third of the shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining third of the shares of common stock vesting on the second-year anniversary of the Grant Date.

On April 3, 2023, the Compensation Committee and Board of the Issuer approved a restricted stock award for 125,000 shares of common stock to Mr. Barreto under the Issuer's 2021 Incentive Award Plan. The restricted shares were then issued on April 5, 2023. The shares are fully vested.

Mr. Barreto is the president of RLB Market Investments, LLC.

On April 3, 2023, the Compensation Committee and Board of the Issuer approved a restricted stock award for 325,000 shares of common stock to Mr. Fernandez under the Issuer's 2021 Incentive Award Plan. The restricted shares were then issued on April 5, 2023. The shares are fully vested.

Does not include 400,000 shares of restricted stock awarded on May 28, 2021, that vests in two equal tranches on the second and third year anniversaries of the grant date.

Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC.

On December 14, 2022 eAperion Partners LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable.

Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC.

On December 14, 2022, RLB Market Investments, LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable.

Mr. Barreto is the president of RLB Market Investments, LLC

On December 14, 2022, RLB Market Investments, LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable.

Mr. Barreto is the president of RLB Market Investments, LLC

On December 14, 2022 eAperion Partners LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable.

Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC.

On December 14, 2022, David Phipps purchased 28,500 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable.

On December 14, 2022, David Phipps purchased 28,500 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable.

The options were granted as an inducement for Ms. Munnik to enter into her employment agreement with the Issuer.

On December 5, 2022, Ms. Munnik entered into a Stock Option Agreement with the Issuer with an effective date of November 14, 2022 pursuant to which Ms. Munnik was granted an option to purchase 50,000 shares of Issuer's common stock, of which options to purchase 25,000 shares of common stock vest immediately on the Grant Date, with options to purchase an additional 10,000 shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining 15,000 shares of common stock vesting on the second-year anniversary of the Grant Date.

The options were granted as an inducement for Mr. Bedwell to enter into his employment agreement with the Issuer.

On December 5, 2022, Mr. Bedwell entered into a Stock Option Agreement with the Issuer with an effective date of November 7, 2022 pursuant to which Mr. Bedwell was granted an option to purchase 50,000 shares of Issuer's common stock, of which options to purchase 25,000 shares of common stock vest immediately on the Grant Date, with options to purchase an additional 10,000 shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining 15,000 shares of common stock vesting on the second-year anniversary of the Grant Date.

Includes 316,000 shares of restricted common stock held by eApeiron Partners LLC, of which Mr. Fernandez is sole and managing partner.

Mr. Fernandez is the sole member and managing partner of eApeiron Partners LLC.

Includes 200,000 shares of common stock held by eApeiron Partners LLC, of which Mr. Fernandez is sole member and managing partner.

Mr. Fernandez is the sole member and managing partner of eApeiron Partners LLC.

The stock options were granted as an equity incentive award.

On July 1, 2022, Mr. Fernandez was granted an option to purchase 70,000 shares of common stock. The option was fully vested, issued outside of any equity compensation plan, with an exercise price of $2.13, and a term of ten years.